Kieuhoa Tran Vo MD
Associate Professor, Pediatrics, UCSF School of Medicine
1825 4th Sreet6TH floorSan Francisco, CA 94143
Fax+1 415-353-2657
Overview of Dr. Vo
Dr. Kieuhoa Vo is a pediatric hematologist/oncologist in San Francisco, CA and is affiliated with multiple hospitals in the area, including UCSF Benioff Children's Hospital Oakland and UCSF Benioff Childrens Hospital. She received her medical degree from Indiana University School of Medicine and has been in practice 9 years. She is one of 53 doctors at UCSF Benioff Children's Hospital Oakland and one of 20 doctors at UCSF Benioff Childrens Hospital who specialize in Pediatric Hematology & Oncology. She has more than 20 publications and over 500 citings.
Education & Training
University of California (San Francisco)Fellowship, Pediatric Hematology/Oncology, 2012 - 2015
Nationwide Children's Hospital/Ohio State UniversityResidency, Pediatrics, 2008 - 2011
Indiana University School of MedicineClass of 2008
Certifications & Licensure
CA State Medical License 2012 - 2026
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Pilot Study to Enable Electronic Laboratory Data Transfer From Participating Institutions to MediData/RAVE Start of enrollment: 2021 Aug 28
Roles: Contact
- NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial Start of enrollment: 2024 Dec 16
Roles: Contact
- Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial) Start of enrollment: 2018 Nov 14
- Join now to see all
Publications & Presentations
PubMed
- A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric and Young Adult Solid Tumors.Filemon S Dela Cruz, Elizabeth Fox, Steven G DuBois, Gregory K Friedman, James M Croop
Pediatric Blood & Cancer. 2025-07-01 - Phase I Study ofI-Metaiodobenzylguanidine With Dinutuximab ± Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Thera...Thomas Cash, Araz Marachelian, Steven G DuBois, Yueh-Yun Chi, Anahit Baregamyan
Journal of Clinical Oncology. 2025-06-23 - A phase 1 dose-escalation study of LY3295668 erbumine as monotherapy and in combination with topotecan and cyclophosphamide in children with relapsed/refractory neurob...Steven G DuBois, Chitose Ogawa, Lucas Moreno, Yaël P Mossé, Matthias Fischer
Cancer. 2025-02-15
Grant Support
- Circulating biomarkers of clinical response to combination targeted therapies in neuroblastomaUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2024–2029
- Circulating biomarkers of clinical response to combination targeted therapies in neuroblastomaNIH/NCI2024–2029
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
